NK

Nilkanth Kadtuji Dange

Active Director Director DIN 10601166
DIN 10601166 First appointment Apr 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nilkanth Kadtuji Dange

Data last updated:

Nilkanth Kadtuji Dange is a Director at Medayurva Pharmaceuticals Private Limited (since 2024). The company operates in Healthcare.

DIN 10601166
Primary Designation Director
Industry Healthcare
First Appointment 23 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Apr 20242024Active

Board colleagues of Nilkanth Kadtuji Dange

Directorship timeline

Open interactive timeline →
Medayurva Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nilkanth Kadtuji Dange

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilkanth Kadtuji Dange

Nilkanth Kadtuji Dange currently holds 1 directorship: Medayurva Pharmaceuticals Private Limited (Director, since 23 Apr 2024).

Nilkanth Kadtuji Dange was first appointed on 23 Apr 2024 as Director at Medayurva Pharmaceuticals Private Limited.

The current boards of Nilkanth Kadtuji Dange's companies include Sudarshan Sakharam Jamdhade (Medayurva Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available